Related Experiment Videos
Initial single-center experience with a new intracoronary stent
Stephan Baldus1, Christian W Hamm, Ralf Köster
1Department of Cardiology, University Hospital, Eppendorf, Hamburg, Germany.
International Journal of Cardiovascular Interventions
|March 8, 2003
Summary
The beStent(TM) intracoronary stent shows promise for treating complex coronary lesions. Its favorable features and successful deployment in 94% of cases suggest a low complication rate and good acute results.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Coronary artery disease necessitates effective revascularization strategies.
- Intracoronary stenting is a common treatment for coronary lesions.
- New stent designs aim to improve procedural success and patient outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of the novel intracoronary beStent(TM).
- To assess the performance of the beStent(TM) in complex coronary lesions and various anatomical locations.
Main Methods:
- A prospective study involving 117 patients who received 126 beStent(TM) devices between July 1996 and February 1997.
- Stent deployment success rates, lesion locations (LAD, RCA, circumflex, vein grafts), and procedural complications were recorded.
- Device features like flexibility, zero shortening, and gold markers were assessed for their utility.
Main Results:
- Successful stent deployment was achieved in 94% of cases, including complex and angulated lesions.
- The stent's gold markers aided precise placement near side-branches and in serial stent applications.
- Low rates of in-hospital complications were observed, including one cardiac death, one subacute stent thrombosis, and one myocardial infarction.
Conclusions:
- The beStent(TM) exhibits favorable characteristics, including high flexibility and useful end-markers.
- The device demonstrated effective use in treating complex coronary lesions with favorable acute results.
- The study indicates a low complication rate associated with the beStent(TM) in this patient cohort.